Register entry
Akebia Therapeutics, Inc.
- Registered sites
- 0
- Drug products
- 4
- Live patents
- 42
- Countries
- 0
- Base
- Unknown
Sites
Facilities
0No registered facilities
This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.
Exclusivity
Patents
42Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| VAFSEO | VADADUSTAT | Jun 2027 |
| VAFSEO | VADADUSTAT | Aug 2027 |
| VAFSEO | VADADUSTAT | Mar 2028 |
| VAFSEO | VADADUSTAT | Apr 2028 |
| VAFSEO | VADADUSTAT | Jun 2034 |
| VAFSEO | VADADUSTAT | Jun 2034 |
| VAFSEO | VADADUSTAT | Nov 2034 |
| VAFSEO | VADADUSTAT | Mar 2036 |
Catalogue
Marketed products
4Showing 4 of 4.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| Auryxia | ferric citrate | TABLET, FILM COATED | NDA |
| VAFSEO | Vadadustat | TABLET, FILM COATED | NDA |
| VAFSEO | Vadadustat | TABLET, FILM COATED | NDA |
| VAFSEO | Vadadustat | TABLET, FILM COATED | NDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.